Physician profile
Marvin A Wayne
NPI 1619903051
$23,949.98
in general payments reported to CMS, 2019-2025
10 companies · $277 in 2025
The $277 reported for 2025 was more than what 88% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $149 · 2021: $400 · 2022: $9,475 · 2023: $1,024 · 2024: $368 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,000 · Food and Beverage: $642 · Education: $26.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,000.00 |
| Food and Beverage | $642.17 |
| Education | $26.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $12,182.74 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $8,738.52 | 2022-2024 | Andexxa |
| Rivanna Medical, INC | $1,048.22 | 2022-2025 | Accuro, Accuro |
| Gilead Sciences, INC. | $538.69 | 2023 | Veklury |
| Stryker Corporation | $503.59 | 2019-2023 | |
| Quidel Corporation | $400.00 | 2021 | |
| Abbott Laboratories | $337.50 | 2022 | |
| Cook Medical LLC | $118.51 | 2024-2025 | Wayne, Rosen |
| Ambu INC. | $57.21 | 2023 | |
| Instrumentation Laboratory Company | $25.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Wayne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.